ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 11 May 2019
Last Applicant/ Owned by
794 Sunrise Blvd.
Mount Bethel
PA
18343
Serial Number
87523966 filed on 11th Jul 2017
Registration Number
N/A
Correspondent Address
Gary D.E. Pierce
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
PHYTO-3
Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary and nutritional supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary food supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary Read More
Classification Information
Class [005]
Pharmaceutical Products
Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary and nutritional supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary food supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements for improving cognitive function; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements for reducing inflammation; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements for managing symptoms of PTSD; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of dietary supplements for managing opioid withdrawal; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of pharmaceutical preparations for the treatment of and for improving cognitive function; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of pharmaceutical preparations for the treatment of and for reducing inflammation; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of pharmaceutical preparations for the treatment of and for managing opioid withdrawal; Omega-3 and extracts from hemp-derived CBD sold as a component ingredient of pharmaceutical preparations for the treatment of and for managing symptoms of PTSD
First Use Date in General
15th Dec 2017
First Use Date in Commerce
15th Dec 2017
Mark Details
Serial Number
No 87523966
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 3340-3-41
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 13th May 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| 11th May 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 13th Oct 2018 | FINAL REFUSAL E-MAILED |
| 13th Oct 2018 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 13th Oct 2018 | SU - FINAL REFUSAL - WRITTEN |
| 19th Sep 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 18th Sep 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 18th Sep 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 13th Sep 2018 | NON-FINAL ACTION E-MAILED |
| 13th Sep 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |